The effect of icu sedation guidelines and pharmacist interventions on clinical outcomes and drug cost

Annals of Pharmacotherapy

Volumn 31, Issue 6, 1997, Pages 689-695

  Devlin, John W ^a,b   Holbrook, Anne M ^c   Fuller, Hugh D ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b HENRY FORD HOSPITAL   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d St Joseph's Hospital   (United States)

Author keywords

Cost analysis; Critical care; Lorazepam; Mechanical ventilation; Midazolam; Pharmacoeconomics; Propofol; Sedation

Indexed keywords

HALOPERIDOL; LORAZEPAM; MIDAZOLAM; MORPHINE; PROPOFOL;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DRUG COST; FEMALE; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PHARMACIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEDATION; TREATMENT OUTCOME;

EID: 0030903101     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100604     Document Type: Article

References (35)

1. Dasta JF, Fuhrman TM, McCandles C. Patterns of prescribing and administering drugs for agitation and pain in patients in a surgical intensive care unit. Crit Care Med 1994;22:974-80.
2. Dasta JF, Fuhrman TM, McCandles C. Use of sedatives and analgesics in a surgical intensive care unit: a follow-up and commentary. Heart Lung 1995;24:76-8.
3. Dattani S, Wong G. Intensive care unit sedation. Hosp Pharm Pract 1996;4:16-21.
4. Cerra FB, Champion H, Chulay M, Groeger J, Hyman A, Loeb L, et al. Critical care in the United States: coordinating intensive care resources for positive and cost-efficient patient outcomes. Anaheim, CA: Society of Critical Care Medicine, 1992.
5. Armstrong DK, Crisp CB. Pharmacoeconomic issues of sedation, analgesia and neuromuscular blockade in critical care. New Horiz 1994;2: 85-93.
6. Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale (letter). Lancet 1974;2:81.
7. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system for acutely ill patients. Crit Care Med 1985; 13: 818-29.
8. Cullen DJ, Civetta JM, Briggs BA, Ferrara LC. Therapeutic intervention scoring system: a method for quantitative comparison of patient care. Crit Care Med 1974;2:57-60.
9. Shafer A, Doze VA, White PF. Pharmacokinetic variability of midazolam infusions in critically ill patients. Crit Care Med 1990;18:1039-41.
10. Malacrida R, Fritz ME, Suter PM, Crevoisier C. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care unit patients. Crit Care Med 1991;20:1123-6.
11. Shelly MP, Mendel L, Park GR. Failure of critically ill patients to metabolize midazolam. Anaesthesia 1987;42:619-26.
12. Shelly MP, Sultan MA, Bodenham A. Midazolam infusions in critically ill patients. Eur J Anaesth 1991;8:21-7.
13. Bauer TM, Titz R, Haberrthur C, Ha HR, Hunkeler W, Sleight A, et al. Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet 1995;356:145-7.
14. Pohlman AS, Simpson KP, Hall JB. Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: a prospective, randomized study. Crit Care Med 1994;22:1241-7.
15. Ariano RE, Kassun DA, Aronson KJ. Comparison of sedative recovery time after midazolam versus diazepam administration. Crit Care Med 1994;22:1492-6.
16. Pohlman AS, Simpson KP, Hall JB. Midazolam versus propofol (letter). Crit Care Med 1995;23:1153.
17. Aitkenhead AR, Willats SM, Park GR, Collins CH, Ledingham IM, Pepperman ML. Comparison of propofol and midazolam for sedation in critically ill patients. Lancet 1989;2:704-9.
18. Ronan KP, Gallagher TJ, George B, Hamby B. Comparison of propofol and midazolam for sedation in intensive care patients. Crit Care Med 1995;23:286-93.
19. Carrasco G, Molina R, Costa J, Soler JM, Cabre L. Propofol vs midazolam in short-, medium-, and long-term sedation in critically ill patients: a cost-benefit analysis. Chest 1993;103:557-64.
20. Valente JF, Anderson GL, Branson RL. Disadvantages of prolonged propofol sedation in the critical care unit. Crit Care Med 1994;2:710-2.
21. DeFriez CB, Wong HC. Seizures and opisthotomies after propofol anesthesia. Anesth Analg 1992;75:630-2.
22. Bennet SN, McNeil MM, Bland LA. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med 1995;333:147-54.
23. Crippen D, Ermakov S. Continuous infusions of haloperidol in critically ill patients (letter). Crit Care Med 1995; 23: 214-5.
24. Adams F. Emergency intravenous sedation of the delirious, medically ill patient. J Clin Psychiatry 1988;49(suppl):22-6.
25. Watling SM, Dasta JF, Seidl EC. Sedatives, analgesics, and paralytics in the ICU. Ann Pharmacother 1997;31:148-53.
26. Streiner DL, Norman GR, Monroe BH. PDQ series: epidemiology. Toronto: BC Decker, 1989:39.
27. Cernaianu AC, DelRossi AJ, Flum DR, Vassilidze TV, Ross SE, Cilley JH, et al. Lorazepam amd midazolam in the intensive care unit: a randomized, prospective, multicenter study of hemodynamics, oxygen transport, efficacy and cost. Crit Care Med 1996;24:222-8.
28. Ramsay M, Savege T, Simpson B. Controlled sedation with alphaxolone-alphadolone. Br Med J 1974;2:656-9.
29. Hansen-Flaschen J, Cowen J, Polomano RC. Beyond the Ramsay scale: need for a validated measure of sedating drug efficacy in the intensive care unit. Crit Care Med 1994;22:732-3.
30. Rudis MI, Guslits BJ, Peterson EL, Hathaway SJ, Angus E, Beis S, et al. Economic impact of prolonged motor weakness complicating neuromuscular blockade in the intensive care unit. Crit Care Med 1996;24:1749-56.
31. Montazeri M, Cook D. Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Crit Care Med 1994;22:1044-8.
32. Zarowitz BJ, Petitta A, Rudis MI, Horst HM, Hyzy R. Bar code documentation of pharmacotherapy services in intensive care units. Pharmacotherapy 1996;16:261-6.
33. Hadbavny AM, Hoyt JW. Promotion of cost-effective benzodiazepine sedation. Am J Hosp Pharm 1993;50:660-1.
34. Tierney M, Carter-Snell C, Cardinal P, Baxter A. Comparison of duration of mechanical ventilation and cost associated with midazolam and lorazepam infusions in critically ill patients. Can J Hosp Pharm 1996;49: 211-5.
35. Shapiro BA, Warren J, Egol AB, Greenbaum DM, Jacobi J, Nasraway S. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Crit Care Med 1995;23:1596-600.